Pearl Street Venture Funds (PSVF)
Pearl Street Venture Funds (PSVF) is dedicated to supporting innovative entrepreneurs by building valuable, entrepreneurial-driven companies and generating impressive returns for limited partners. Founded by experienced entrepreneurs and veteran venture capitalists, PSVF primarily invests in life sciences companies with transformative innovations.
Industries
N/A
Nr. of Employees
small (1-50)
Portfolio
Founded on the scientific discoveries of Dr. Mark R. Kelley, focusing on APE1/Ref-1 redox protein signaling.
#Biotechnology
Developed microbial detection technology for environmental monitoring. Acquired by Yamatake, Inc.
#Pharmaceutical, Biotechnology, Healthcare
Focused on therapies for CNS disorders and other conditions. Acquired by Eli Lilly and Company, Inc.
#Biotechnology
Full-service parenteral contract manufacturer. Majority purchase by Arlington Capital Partners.
#Pharmaceutical Manufacturing
#Technology
Advanced a proprietary approach for immunomodulatory therapy based on synthetic ligands for the TLR2 receptor.
#Biotechnology
Founded on the scientific discoveries of Dr. Mark R. Kelley, focusing on APE1/Ref-1 redox protein signaling.
#Biotechnology
Developed microbial detection technology for environmental monitoring. Acquired by Yamatake, Inc.
#Pharmaceutical, Biotechnology, Healthcare
Focused on therapies for CNS disorders and other conditions. Acquired by Eli Lilly and Company, Inc.
#Biotechnology
Full-service parenteral contract manufacturer. Majority purchase by Arlington Capital Partners.
#Pharmaceutical Manufacturing
#Technology
Advanced a proprietary approach for immunomodulatory therapy based on synthetic ligands for the TLR2 receptor.
#Biotechnology